Free Trial
NASDAQ:IRMD

Iradimed Q1 2025 Earnings Report

Iradimed logo
$51.44 -0.52 (-1.00%)
As of 01:07 PM Eastern

Iradimed EPS Results

Actual EPS
N/A
Consensus EPS
$0.43
Beat/Miss
N/A
One Year Ago EPS
N/A

Iradimed Revenue Results

Actual Revenue
N/A
Expected Revenue
$19.33 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Iradimed Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Thursday, May 1, 2025
Conference Call Time
11:00AM ET

Conference Call Resources

Remove Ads

Iradimed Earnings Headlines

Undiscovered Gems in the US Market for April 2025
The Last Time This Happened, Americans Lost Billions
Wall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warning signs are everywhere. Economist Addison Wiggin reveals what’s coming.
See More Iradimed Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Iradimed? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Iradimed and other key companies, straight to your email.

About Iradimed

Iradimed (NASDAQ:IRMD) Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

View Iradimed Profile

More Earnings Resources from MarketBeat